As of 2026-03-19, the Fair Value of Integra Lifesciences Holdings Corp (IART) is -33.13 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.90 USD, the upside of Integra Lifesciences Holdings Corp is -472.28%.
With the market price of 8.90 USD and our fair value calculation, Integra Lifesciences Holdings Corp (IART) is not a good investment. Investing in IART stocks now will result in a potential loss of 472.28%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 169.10 | 180.60 | 67.74 | -6.94 | -516.47 | -21.20 |
| YoY growth | 26.29% | 6.80% | -62.49% | -110.25% | -7,337.70% | -1,495.47% |
| Market Cap (mil) | 693.67 |
| P/E | |
| Forward P/E |
| EPS | -6.63 |
| Avg earnings growth rate | -1,495.47% |
| TTM earnings | -516.47 |